30
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) on Chemotherapy-Induced Myelosuppression in Patients with Chronic Lymphocytic Leukemia: A Crossover Study

, &
Pages 503-508 | Received 10 Jul 1996, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (6)

William G Wierda, Michael J Keating & Susan O??Brien. (2004) Refractory Chronic Lymphocytic Leukemia. American Journal of Cancer 3:3, pages 163-178.
Crossref
William G. Wierda. (2003) Immunologic monitoring in chronic lymphocytic leukemia. Current Oncology Reports 5:5, pages 419-425.
Crossref
Susan N. O’Brien, Nicole M.A. Blijlevens, Tahsine H. Mahfouz & Elias J. Anaissie. (2003) Infections in Patients with Hematological Cancer: Recent Developments. Hematology 2003:1, pages 438-472.
Crossref
E Kass, J Parker, J Schlom & J.W Greiner. (2000) COMPARATIVE STUDIES OF THE EFFECTS OF RECOMBINANT GM-CSF AND GM-CSF ADMINISTERED VIA A POXVIRUS TO ENHANCE THE CONCENTRATION OF ANTIGEN- PRESENTING CELLS IN REGIONAL LYMPH NODES. Cytokine 12:7, pages 960-971.
Crossref
Robak, Błoński, Kasznicki, Konopka, Ceglarek, Dmoszyńska, Soroka‐Wojtaszko, Skotnicki, Nowak, Dwilewicz‐Trojaczek, Tomaszewska, Hellmann, Lewandowski, Kuliczkowski, Potoczek, Zdziarska, Hansz, Kroll, Komarnicki, Hołowiecki & Grieb. (2001) Cladribine with or without prednisone in the treatment of previously treated and untreated B‐cell chronic lymphocytic leukaemia — updated results of the multicentre study of 378 patients. British Journal of Haematology 108:2, pages 357-368.
Crossref
Filippo Russo, Stefano Guadagni, Gioacchino Mattera, Giuseppe Esposito & Giuseppe Abate. (2009) Combination of granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) and erythropoietin (EPO) for the treatment of advanced non‐responsive chronic lymphocytic leukemia. European Journal of Haematology 63:5, pages 325-331.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.